Zeng, Yimin – Trademark Portfolio

Entity Type: 01

Zeng, Yimin holds 2 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 11 (Environmental Control) — 1 filings in this category. The portfolio also extends into Class 5 (Pharmaceuticals) across 2 Nice Classification classes. Currently, 2 trademarks are registered. Notable registered marks include BCUELOV and ONEMAXGO. The owner is based in Dongguan, Guangdong.

Quanmianling, Dongcheng Street

Room 402, No. 28, Lane 2

Dongguan, Guangdong 523000 , CN

2 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

ONEMAXGO
ONEMAXGO
Registered 2023
BCUELOV
BCUELOV
Registered 2020

Trademark Classifications

Zeng, Yimin's trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

11
Environmental Control (1 filing)

Apparatus for lighting, heating, steam generating, cooking, refrigerating, drying

5
Pharmaceuticals (1 filing)

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

Frequently Asked Questions

How many trademarks does Zeng, Yimin have?

Zeng, Yimin has 2 U.S. trademarks filed with the USPTO. Of these, 2 registered.

What trademark classes does Zeng, Yimin file in?

Zeng, Yimin files trademarks across 2 Nice Classification classes. The most active classes are Class 11 (Environmental Control), Class 5 (Pharmaceuticals). Class 11 covers apparatus for lighting, heating, steam generating, cooking, refrigerating, drying.

What are Zeng, Yimin's most well-known trademarks?

Zeng, Yimin's registered trademark portfolio includes well-known marks such as BCUELOV and ONEMAXGO. These are among 2 currently registered trademarks in the portfolio.

What is Zeng, Yimin's trademark registration success rate?

Zeng, Yimin has a 100% trademark registration rate, with 2 out of 2 resolved applications resulting in successful registration. Currently, 0 applications are pending review.